Idifarma provides contract development and manufacturing services for niche and highly potent generic or innovative drugs

Pharmaceutical R&D and Manufacturing Services

Idifarma is an independent, privately-owned pharmaceutical CDMO based in Spain and specializing in highly potent drugs.

With an experienced staff of 130+ people and over 100 international clients, Idifarma provides a full range of services covering most of the lifecycle of any pharmaceutical product from first pre-formulation trials to commercial manufacturing: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, stability studies, regulatory affairs, GMP contract manufacturing and packaging for clinical or commercial use.

Its state-of-the-art facility features a purpose-built high containment plant for GMP manufacturing of oral solid dosage forms, for both highly potent and non-potent drugs.

Idifarma’s expertise, capabilities and proven track record make it the perfect partner for the development of your projects.


Covid-19 Announcement

IDIFARMA is fully committed to the well-being of our employees, the quality of the services we provide to our valuable clients and our contribution to the general health of all people.


Idifarma will attend the following events during 2020 Would you like to meet us? Contact us at to schedule a meeting!


Únete a @Idifarma en este nuevo proceso de selección abierto:

¡Te esperamos!

¿Quieres formar parte de @Idifarma? Tenemos un nuevo proceso de selección abierto:


We are pleased to present the new website of GONMISOL. With this new launch we continue with the strategy of updating the Group's WEB pages. Hope you like it.

SUANFARMA Italia at a glance with the new corporate video. a través de @YouTube

An exciting storytelling that celebrates our values, the quality and passion with which we do our daily work.


"@Idifarma is well respected in the industry and I'm looking forward to contributing to its continued success and future growth" Alfredo Gomez, Head of Site of Idifarma.

Read the full article here!

Load More...

Do you want to receive the latest news from Idifarma?

Utilizamos cookies propias y de terceros para realizar el análisis de la navegación de los usuarios y mejorar nuestros servicios. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración pulse aquí ACEPTAR

Aviso de cookies